Sample information curated by ChIP-Atlas

Antigen

Antigen Class
No description
Antigen
NA

Cell type

Cell type Class
No description
Cell type
NA
NA
NA

Attributes by original data submitter

Sample

ENA-CHECKLIST
ERC000011
ENA-FIRST-PUBLIC
2014-01-05
ENA-LAST-UPDATE
2013-10-24
External Id
SAMEA2242012
INSDC center alias
BCO
INSDC center name
University of Oulu
INSDC first public
2014-01-05T17:02:23Z
INSDC last update
2013-10-24T09:57:44Z
INSDC status
public
Submitter Id
VCaP ChIP-seq3
common name
human
sample name
VCaP ChIP-seq3

Sequenced DNA Library

library_name
H3K27me3_VCaP
library_strategy
ChIP-Seq
library_source
GENOMIC
library_selection
ChIP
library_construction_protocol
Chromatin immunoprecipitation (ChIP) assays were performed in prostate cancer cell line VCaP. To induce the AR activity prior to ChIP, 80% confluent VCaP cells were treated with 1nM of the synthetic androgen methyltrienolone (R1881, dissolved in ethanol) for 24 hours. The ChIPed DNA was blunted and phosphorylated with T4 DNA polymerase, Klenow DNA polymerase and T4 polynucleotide kinase. Subsequently, the DNA fragments was added an A nucleotide to the 3’ end using Klenow exo- (3’ to 5’ exonuclease activity minus). Illumina/Solexa amplification and sequencing adapters were ligated to the DNA-fragments and were size-selected on 2% agarose gel for 150-450bp fragments. After enriched by 16 cycles of PCR amplification, DNA fragments were size-selected again on a 2% agarose gel (150- 450 bp). Purified DNA (Qiagen gel purification kit) was quantified (Nanodrop 1000 spectrophotometer) and subjected to massively parallel sequencing (Illumina platform).

Sequencing Platform

instrument_model
Illumina HiSeq 2000

hg38

Number of total reads
20100693
Reads aligned (%)
88.7
Duplicates removed (%)
2.1
Number of peaks
233 (qval < 1E-05)

hg19

Number of total reads
20100693
Reads aligned (%)
87.8
Duplicates removed (%)
3.2
Number of peaks
568 (qval < 1E-05)

Base call quality data from DBCLS SRA